Growth hormone secretagogues: realistic expectations

CJC-1295 and ipamorelin are growth-hormone-releasing peptides studied mostly in short-term healthy adult trials. They raise GH/IGF-1 transiently. Body recomp claims often outpace the evidence. Side effects to watch: insulin resistance over time, water retention. Long-term cancer-risk signal is theoretical but takes large datasets to rule out.